Literature DB >> 29152758

The role of genetics in hepatic fibrosis among hepatitis C virus patients.

Heiyoung Park1, Thomas R O'Brien2, Barbara Rehermann1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29152758      PMCID： PMC6886880          DOI： 10.1002/hep.29659

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Authors:  Ludmila Prokunina-Olsson; Brian Muchmore; Wei Tang; Ruth M Pfeiffer; Heiyoung Park; Harold Dickensheets; Dianna Hergott; Patricia Porter-Gill; Adam Mumy; Indu Kohaar; Sabrina Chen; Nathan Brand; McAnthony Tarway; Luyang Liu; Faruk Sheikh; Jacquie Astemborski; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Timothy R Morgan; David L Thomas; Barbara Rehermann; Raymond P Donnelly; Thomas R O'Brien
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

Review 2.  Host - hepatitis C viral interactions: The role of genetics.

Authors:  Markus H Heim; Pierre-Yves Bochud; Jacob George
Journal:  J Hepatol       Date:  2016-10       Impact factor: 25.083

3.  Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

Authors:  Ewa Terczyńska-Dyla; Stephanie Bibert; Francois H T Duong; Ilona Krol; Sanne Jørgensen; Emilie Collinet; Zoltán Kutalik; Vincent Aubert; Andreas Cerny; Laurent Kaiser; Raffaele Malinverni; Alessandra Mangia; Darius Moradpour; Beat Müllhaupt; Francesco Negro; Rosanna Santoro; David Semela; Nasser Semmo; Markus H Heim; Pierre-Yves Bochud; Rune Hartmann
Journal:  Nat Commun       Date:  2014-12-23       Impact factor: 14.919

4.  Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

Authors:  Salvatore Petta; Luca Valenti; Antonino Tuttolomondo; Paola Dongiovanni; Rosaria Maria Pipitone; Calogero Cammà; Daniela Cabibi; Vito Di Marco; Anna Ludovica Fracanzani; Sara Badiali; Valerio Nobili; Silvia Fargion; Stefania Grimaudo; Antonio Craxì
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

5.  IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.

Authors:  Mohammed Eslam; Duncan McLeod; Kebitsaone Simon Kelaeng; Alessandra Mangia; Thomas Berg; Khaled Thabet; William L Irving; Gregory J Dore; David Sheridan; Henning Grønbæk; Maria Lorena Abate; Rune Hartmann; Elisabetta Bugianesi; Ulrich Spengler; Angela Rojas; David R Booth; Martin Weltman; Lindsay Mollison; Wendy Cheng; Stephen Riordan; Hema Mahajan; Janett Fischer; Jacob Nattermann; Mark W Douglas; Christopher Liddle; Elizabeth Powell; Manuel Romero-Gomez; Jacob George
Journal:  Nat Genet       Date:  2017-04-10       Impact factor: 38.330

6.  Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

Authors:  Mohammed Eslam; Ahmed M Hashem; Reynold Leung; Manuel Romero-Gomez; Thomas Berg; Gregory J Dore; Henry L K Chan; William L Irving; David Sheridan; Maria L Abate; Leon A Adams; Alessandra Mangia; Martin Weltman; Elisabetta Bugianesi; Ulrich Spengler; Olfat Shaker; Janett Fischer; Lindsay Mollison; Wendy Cheng; Elizabeth Powell; Jacob Nattermann; Stephen Riordan; Duncan McLeod; Nicola J Armstrong; Mark W Douglas; Christopher Liddle; David R Booth; Jacob George; Golo Ahlenstiel
Journal:  Nat Commun       Date:  2015-03-05       Impact factor: 14.919

7.  Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.

Authors:  Taylor Aiken; Ari Garber; Dawn Thomas; Nicole Hamon; Rocio Lopez; Rajesh Konjeti; Arthur McCullough; Nizar Zein; John Fung; Medhat Askar; Binu V John
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

8.  The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.

Authors:  Adelle P McFarland; Stacy M Horner; Abigail Jarret; Rochelle C Joslyn; Eckart Bindewald; Bruce A Shapiro; Don A Delker; Curt H Hagedorn; Mary Carrington; Michael Gale; Ram Savan
Journal:  Nat Immunol       Date:  2013-11-17       Impact factor: 25.606
  8 in total
  1 in total

Review 1.  What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?

Authors:  Thomas R O'Brien; Sarah S Jackson
Journal:  J Interferon Cytokine Res       Date:  2019-06-04       Impact factor: 2.607
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.